InMed Pharmaceuticals and Mentari Therapeutics Announce Merger and US$290 Million Private Placement to Accelerate Migraine Therapies

Leila Ahmed North America Legal Chronicle
Tagged:

Gibson, Dunn & Crutcher LLP has advised Mentari Therapeutics, Inc. Norton Rose Fulbright LLP and Norton Rose Fulbright Canada LLP have advised InMed Pharmaceuticals, Inc. InMed…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here